Emmanuel Caeymaex
Corporate Officer/Principal bei UCB
Profil
Emmanuel Caeymaex is currently the Executive VP & Head-Immunology Solutions at UCB SA. Previously, he worked as the Director at Dermira, Inc. in 2017 and as the President at UCB Japan Co. Ltd.
from 2006 to 2011.
He holds a graduate degree from Université Catholique de Louvain and CEMS The Global Alliance in Management Education.
Aktive Positionen von Emmanuel Caeymaex
| Unternehmen | Position | Beginn |
|---|---|---|
| UCB | Corporate Officer/Principal | 01.03.1994 |
Ehemalige bekannte Positionen von Emmanuel Caeymaex
| Unternehmen | Position | Ende |
|---|---|---|
| DERMIRA, INC. | Director/Board Member | 06.11.2017 |
| UCB Japan Co. Ltd. | President | 01.06.2011 |
Ausbildung von Emmanuel Caeymaex
| Université Catholique de Louvain | Graduate Degree |
| CEMS The Global Alliance in Management Education | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| UCB | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| UCB Japan Co. Ltd. | |
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
